BR0315458A - Utilização de tenatoprazol - Google Patents

Utilização de tenatoprazol

Info

Publication number
BR0315458A
BR0315458A BR0315458-0A BR0315458A BR0315458A BR 0315458 A BR0315458 A BR 0315458A BR 0315458 A BR0315458 A BR 0315458A BR 0315458 A BR0315458 A BR 0315458A
Authority
BR
Brazil
Prior art keywords
tenatoprazole
esophageal
dyspepsia
gastro
atypical
Prior art date
Application number
BR0315458-0A
Other languages
English (en)
Inventor
Francois Schutze
Suzy Charbit
Herve Ficheux
Michel Homerin
Alain Taccoen
Yoshio Inaba
Original Assignee
Sidem Pharma
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sidem Pharma, Mitsubishi Pharma Corp filed Critical Sidem Pharma
Publication of BR0315458A publication Critical patent/BR0315458A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

"UTILIZAçãO DE TENATOPRAZOL". A invenção refere-se a uma nova indicação terapêutica do tenatoprazol. O tenatoprazol, bem como seus sais, pode ser utilizado na fabricação de um medicamento para o tratamento dos sintomas atípicos e esofagianos do refluxo gastro-esofagiano, hemorragias digestivas e dispepsias.
BR0315458-0A 2002-10-21 2003-10-21 Utilização de tenatoprazol BR0315458A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0213113A FR2845915B1 (fr) 2002-10-21 2002-10-21 Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
PCT/FR2003/003122 WO2004037255A1 (fr) 2002-10-21 2003-10-21 Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien

Publications (1)

Publication Number Publication Date
BR0315458A true BR0315458A (pt) 2005-08-23

Family

ID=32050603

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315458-0A BR0315458A (pt) 2002-10-21 2003-10-21 Utilização de tenatoprazol

Country Status (17)

Country Link
US (2) US20070066659A1 (pt)
EP (2) EP1553943B1 (pt)
JP (1) JP2006508083A (pt)
KR (1) KR101186034B1 (pt)
CN (2) CN1753674A (pt)
AT (1) ATE395060T1 (pt)
AU (1) AU2003285426A1 (pt)
BR (1) BR0315458A (pt)
CA (1) CA2503212C (pt)
CY (1) CY1108248T1 (pt)
DE (1) DE60321025D1 (pt)
DK (2) DK2014290T3 (pt)
ES (2) ES2412395T3 (pt)
FR (1) FR2845915B1 (pt)
PT (1) PT1553943E (pt)
SI (1) SI1553943T1 (pt)
WO (1) WO2004037255A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPH0643426B2 (ja) 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
SE9603725D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New teatment
ES2559766T3 (es) * 1998-05-18 2016-02-15 Takeda Pharmaceutical Company Limited Comprimidos disgregables en la boca
EP1154771A4 (en) * 1999-02-26 2005-04-20 Nitromed Inc INHIBITORS OF THE PROTON NITROSIS AND NITROSYL PUMP, COMPOSITIONS AND METHODS OF USE
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
SE9903831D0 (sv) * 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
AU2003241464A1 (en) * 2002-05-17 2003-12-02 Eisai Co., Ltd. Compositions and methods using proton pump inhibitors
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique

Also Published As

Publication number Publication date
EP2014290A3 (fr) 2009-03-04
EP2014290B1 (fr) 2013-01-23
FR2845915B1 (fr) 2006-06-23
DK2014290T3 (da) 2013-05-06
DE60321025D1 (de) 2008-06-26
AU2003285426A8 (en) 2004-05-13
ES2412395T3 (es) 2013-07-11
KR20050090374A (ko) 2005-09-13
CA2503212A1 (fr) 2004-05-06
WO2004037255A1 (fr) 2004-05-06
US20110152314A1 (en) 2011-06-23
CN102920705A (zh) 2013-02-13
EP1553943A1 (fr) 2005-07-20
ATE395060T1 (de) 2008-05-15
EP1553943B1 (fr) 2008-05-14
KR101186034B1 (ko) 2012-09-25
DK1553943T3 (da) 2008-09-15
ES2306905T3 (es) 2008-11-16
PT1553943E (pt) 2008-08-20
JP2006508083A (ja) 2006-03-09
US20070066659A1 (en) 2007-03-22
CN1753674A (zh) 2006-03-29
AU2003285426A1 (en) 2004-05-13
FR2845915A1 (fr) 2004-04-23
CA2503212C (fr) 2012-03-13
CY1108248T1 (el) 2014-02-12
SI1553943T1 (sl) 2008-12-31
EP2014290A2 (fr) 2009-01-14

Similar Documents

Publication Publication Date Title
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
NO20065079L (no) Materialer og metoder for behandling av koaguleringssykdommer
BRPI0516842A (pt) compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por lxr alfa e/ou lxr beta agonistas e uso desses compostos
IS2696B (is) Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð
UY30481A1 (es) Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos.
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
SE0301882D0 (sv) New use I
BRPI0515577A (pt) compostos de carbonila que podem ser empregados como inibidores de fator xa de coagulação
BRPI0513379A (pt) derivados de sulfonamida
BRPI0518907A2 (pt) compostos, processo para a sua manufatura, composiÇÕes farmacÊuticas que os compreendem, mÉtodo para o tratamento e/ou prevenÇço de enfermidades que estço associadas com a modulaÇço de receptores de h3 e sua utilizaÇço
UY27462A1 (es) Derivados de quinolina
BRPI0519620A2 (pt) compostos, processo para a sua manufatura, composiÇÕes farmacÊuticas que os compreendem, mÉtodo para o tratamento terapÊutico e/ou profilÁtico de enfermidades que sço moduladas por agonistas alfa-lxr e/ou beta-lxr e utilizaÇço desses compostos
BRPI0606502A2 (pt) compostos; processo para a fabricação de compostos; composições farmacêuticas; método para o tratamento ou prevenção de doenças que são associadas com a modulação de receptores h3; método para o tratamento ou prevenção de obesidade em um ser humano ou animal; método de tratamento ou prevenção de diabetes tipo ii em um ser humano ou animal e usos de compostos
AR041942A1 (es) Derivados de 10-oxa -1-aza-dibenzo [a,d] ciclohepteno-7-carboxilico como antagonistas ccr1 para el tratamiento de la enfermedad desmielinizante inflamatoria
RU2007122391A (ru) S-миртазапин для лечения приливов
EA200401319A1 (ru) Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине
SE0201940D0 (sv) New combination II
BR0315458A (pt) Utilização de tenatoprazol
ATE446098T1 (de) Verwendung von polyethylenglycol bei entzündungsbedingten topischen erkrankungen oder erkrankungen und wundheilung
ME00549B (me) Upotreba inhibitora il-18 za liječenje i/ili prevenciju srčanih oboljenja
DE50310038D1 (de) Hemmstoffe der urokinase, ihre herstellung und verwendung
BRPI0514099A (pt) composições farmacêuticas, compostos, processo para a sua manufatura, método para o tratamento terapêutico e/ou profilático de enfermidades e utilização dos compostos
ATE396979T1 (de) Heteroarylacetamide als faktor xa inhibitoren
DK1664044T3 (da) Monohydreret natriumsalt af S-tenatoprazol og dets anvendelse i form af en protonpumpehæmmer

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]